Concepedia
Statistics
Publications
8
Citations
444
H-Index
Active since
2002
Affiliations
Allergan (United States)(Current)
Johns Hopkins University
Minnesota Eye Consultants
Johns Hopkins Medicine
AbbVie (United States)
William C. Christie is an author at Allergan (United States).
Publications per year
2002–2023
Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial
Richard A. Lewis, William C. Christie, Douglas G. Day et al. · American Journal of Ophthalmology · 2016 · 123 citations · Full text
24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
E. Randy Craven, Thomas R. Walters, William C. Christie et al. · Drugs · 2019 · 97 citations · Full text
Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial
Sanjay Asrani, Alan L. Robin, Janet B. Serle et al. · American Journal of Ophthalmology · 2019 · 83 citations
Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: Phase 3 study
Satish Modi, Robert Lehmann, Thomas R. Walters et al. · Journal of Cataract & Refractive Surgery · 2013 · 43 citations
Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure
Henry Jampel, Jason Bacharach, Wang-Pui Sheu et al. · American Journal of Ophthalmology · 2002 · 39 citations
1–5 of 8